Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 4c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Champions Oncology (CSBR) Tops Q1 EPS by 6c
• Deutsche Bank Starts Associated British Foods (ABF:LN) (ASBFY) at Hold